Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
A novel dominant mutation in the SOX10 gene in a Chinese family with Waardenburg syndrome type II.
|
30628718 |
2019 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
This is the first truncating mutation in exon 3 of SOX10 that is associated with neurological symptoms in Waardenburg syndrome.
|
29792164 |
2018 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Abnormalities in SOX10 are associated with Waardenburg syndrome Types II and IV, and these patients have recognizable clinical features.
|
29216801 |
2018 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Human SOX10 mutations lead to various diseases including Waardenburg syndrome, Hirschsprung disease, peripheral demyelinating neuropathy, central leukodystrophy, Kallmann syndrome and various combinations thereof.
|
29361054 |
2018 |
Waardenburg Syndrome
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The mutation is associated with distinctive phenotypic profile (association of anosmia and chronic constipation with SOX10 mutations) and could further improve diagnosis and counseling of WS in the Iranian population and can contribute to phenotype-directed genetic analysis.
|
28390600 |
2017 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
While type I is tightly associated to PAX3 mutations, WS type II (WS2) remains partly enigmatic with mutations in known genes (MITF, SOX10) accounting for only 30% of the cases.
|
28236341 |
2017 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
SOX10 mutations are usually associated with a more severe phenotype of WS with peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, and Hirschsprung disease.
|
28544110 |
2017 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The mutation is associated with distinctive phenotypic profile (association of anosmia and chronic constipation with SOX10 mutations) and could further improve diagnosis and counseling of WS in the Iranian population and can contribute to phenotype-directed genetic analysis.
|
28390600 |
2017 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Functional analysis of a SOX10 gene mutation associated with Waardenburg syndrome II.
|
28893539 |
2017 |
Waardenburg Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Clinical re-evaluation of these probands shows that some of them have subtle syndromic findings, while none of them meets clinical criteria for the diagnosis of the associated syndrome (Waardenburg (SOX10 and MITF), Kallmann (CHD7 and SOX10), Noonan/LEOPARD (PTPN11), CHARGE (CHD7), or Kabuki (KMT2D).
|
27562378 |
2016 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Our result conform the thesis that heterozygous deletions at SOX10 is an important pathogenicity for WS, and present as autosomal dominant inheritance.
|
26296878 |
2015 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SOX10, one of the genes contributing to syndromic hearing loss, induce a large range of phenotypes, including several subtypes of Waardenburg syndrome and Kallmann syndrome with deafness.
|
25256313 |
2015 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Molecular analysis detected a de novo p.Leu145Pro mutation in SOX10, which has previously been reported in a patient with WS and Hirschsprung disease.
|
26228106 |
2015 |
Waardenburg Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
Many genes have been linked to WS, including PAX3, MITF, SNAI2, EDNRB, EDN3, and SOX10, and many additional genes have been associated with disorders with phenotypic overlap with WS.
|
25932447 |
2015 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Chronic constipation may be recognized as indicative of a SOX10 mutation in patients with Waardenburg syndrome.
|
24582978 |
2014 |
Waardenburg Syndrome
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
In addition, mutations in SOX10 are also responsible for an extended syndrome involving peripheral and central neurological phenotypes, referred to as PCWH (peripheral demyelinating neuropathy, central dysmyelinating leucodystrophy, Waardenburg syndrome, Hirschsprung disease).
|
24311220 |
2014 |
Waardenburg Syndrome
|
0.600 |
Biomarker
|
disease |
BEFREE |
This study adds to the existing body of knowledge by characterizing a 2.4 Mb deletion [arr[hg19] 22q12.3-q13.1 (36467502-38878207)x1] encompassing SOX10 and 53 additional RefSeq genes in a 15-year-old female with atypical WS.
|
24715709 |
2014 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The novel heterozygous c.259-260delCT mutation in the SOX10 gene was considered to be the cause of Waardenburg syndrome in the proband.
|
24735604 |
2014 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
SOX10 mutations have been found in patients with type II and type IV WS (i.e., with Hirschsprung disease), more complex syndromes, and partial forms of the disease.
|
24845202 |
2014 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
It has been implicated in Waardenburg syndrome (WS), a rare disorder characterized by the association between pigmentation abnormalities and deafness, but SOX10 mutations cause a variable phenotype that spreads over the initial limits of the syndrome definition.
|
23643381 |
2013 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Fifteen patients with Waardenburg syndrome and different SOX10 mutations were studied retrospectively.
|
23237859 |
2013 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Lately it has been suggested that whole SOX10 gene deletions can be encountered when testing for WS.
|
22842075 |
2012 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Recently, we identified some novel WS-associated mutations in PAX3 and SOX10 in a cohort of Chinese WS patients.
|
21965087 |
2012 |
Waardenburg Syndrome
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
Alu-mediated deletion of SOX10 regulatory elements in Waardenburg syndrome type 4.
|
22378281 |
2012 |
Waardenburg Syndrome
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The recent identification of a deletion encompassing three of the SOX10 regulatory elements in a patient presenting with another WS subtype, WS4, defined by its association with Hirschsprung disease, led us to search for deletions and point mutations within the MITF and SOX10 regulatory elements in 28 yet unexplained WS2 cases.
|
22848661 |
2012 |